(2S)-N-[(2S)-1-[[(2S,3S,4S)-4-amino-1-cyclohexyl-5-cyclopropyl-3-methylpentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-2-benzyl-3-(2-methyl-1-morpholin-4-yl-1-oxopropan-2-yl)sulfonylpropanamide

C39H60N6O6S — CID 59839033

IUPAC(2S)-N-[(2S)-1-[[(2S,3S,4S)-4-amino-1-cyclohexyl-5-cyclopropyl-3-methylpentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-2-benzyl-3-(2-methyl-1-morpholin-4-yl-1-oxopropan-2-yl)sulfonylpropanamide
SMILESC[C@H]([C@H](CC1CCCCC1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)CS(=O)(=O)C(C)(C)C(=O)N1CCOCC1)[C@@H](N)CC1CC1
InChIInChI=1S/C39H60N6O6S/c1-27(33(40)21-30-14-15-30)34(22-29-12-8-5-9-13-29)43-37(47)35(23-32-24-41-26-42-32)44-36(46)31(20-28-10-6-4-7-11-28)25-52(49,50)39(2,3)38(48)45-16-18-51-19-17-45/h4,6-7,10-11,24,26-27,29-31,33-35H,5,8-9,12-23,25,40H2,1-3H3,(H,41,42)(H,43,47)(H,44,46)/t27-,31+,33-,34-,35-/m0/s1
InChIKeyNDAGRVNTZYWUSP-OYWTUCQVSA-N
MW741.01 g/mol
LogP3.57
Rot. Bonds18

About (2S)-N-[(2S)-1-[[(2S,3S,4S)-4-amino-1-cyclohexyl-5-cyclopropyl-3-methylpentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-2-benzyl-3-(2-methyl-1-morpholin-4-yl-1-oxopropan-2-yl)sulfonylpropanamide

(2S)-N-[(2S)-1-[[(2S,3S,4S)-4-amino-1-cyclohexyl-5-cyclopropyl-3-methylpentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-2-benzyl-3-(2-methyl-1-morpholin-4-yl-1-oxopropan-2-yl)sulfonylpropanamide (PubChem CID 59839033) has the molecular formula C39H60N6O6S and a molecular weight of 741.01 g/mol. Its IUPAC name is (2S)-N-[(2S)-1-[[(2S,3S,4S)-4-amino-1-cyclohexyl-5-cyclopropyl-3-methylpentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-2-benzyl-3-(2-methyl-1-morpholin-4-yl-1-oxopropan-2-yl)sulfonylpropanamide.

Molecular Properties

Compound Name(2S)-N-[(2S)-1-[[(2S,3S,4S)-4-amino-1-cyclohexyl-5-cyclopropyl-3-methylpentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-2-benzyl-3-(2-methyl-1-morpholin-4-yl-1-oxopropan-2-yl)sulfonylpropanamide
PubChem CID59839033
Molecular FormulaC39H60N6O6S
Molecular Weight741.01 g/mol
Exact Mass740.43
IUPAC Name(2S)-N-[(2S)-1-[[(2S,3S,4S)-4-amino-1-cyclohexyl-5-cyclopropyl-3-methylpentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-2-benzyl-3-(2-methyl-1-morpholin-4-yl-1-oxopropan-2-yl)sulfonylpropanamide
SMILESC[C@H]([C@H](CC1CCCCC1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)CS(=O)(=O)C(C)(C)C(=O)N1CCOCC1)[C@@H](N)CC1CC1
InChIInChI=1S/C39H60N6O6S/c1-27(33(40)21-30-14-15-30)34(22-29-12-8-5-9-13-29)43-37(47)35(23-32-24-41-26-42-32)44-36(46)31(20-28-10-6-4-7-11-28)25-52(49,50)39(2,3)38(48)45-16-18-51-19-17-45/h4,6-7,10-11,24,26-27,29-31,33-35H,5,8-9,12-23,25,40H2,1-3H3,(H,41,42)(H,43,47)(H,44,46)/t27-,31+,33-,34-,35-/m0/s1
InChIKeyNDAGRVNTZYWUSP-OYWTUCQVSA-N
XLogP3.57
TPSA176.58 Ų
H-Bond Donors4
H-Bond Acceptors8
Rotatable Bonds18
Heavy Atoms52
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500741.01
LogP ≤ 53.57
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 108

Analyze (2S)-N-[(2S)-1-[[(2S,3S,4S)-4-amino-1-cyclohexyl-5-cyclopropyl-3-methylpentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-2-benzyl-3-(2-methyl-1-morpholin-4-yl-1-oxopropan-2-yl)sulfonylpropanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-N-[(2S)-1-[[(2S,3S,4S)-4-amino-1-cyclohexyl-5-cyclopropyl-3-methylpentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-2-benzyl-3-(2-methyl-1-morpholin-4-yl-1-oxopropan-2-yl)sulfonylpropanamide?
The IUPAC name of (2S)-N-[(2S)-1-[[(2S,3S,4S)-4-amino-1-cyclohexyl-5-cyclopropyl-3-methylpentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-2-benzyl-3-(2-methyl-1-morpholin-4-yl-1-oxopropan-2-yl)sulfonylpropanamide (CID 59839033) is (2S)-N-[(2S)-1-[[(2S,3S,4S)-4-amino-1-cyclohexyl-5-cyclopropyl-3-methylpentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-2-benzyl-3-(2-methyl-1-morpholin-4-yl-1-oxopropan-2-yl)sulfonylpropanamide.
What is the SMILES notation for (2S)-N-[(2S)-1-[[(2S,3S,4S)-4-amino-1-cyclohexyl-5-cyclopropyl-3-methylpentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-2-benzyl-3-(2-methyl-1-morpholin-4-yl-1-oxopropan-2-yl)sulfonylpropanamide?
The canonical SMILES for (2S)-N-[(2S)-1-[[(2S,3S,4S)-4-amino-1-cyclohexyl-5-cyclopropyl-3-methylpentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-2-benzyl-3-(2-methyl-1-morpholin-4-yl-1-oxopropan-2-yl)sulfonylpropanamide is C[C@H]([C@H](CC1CCCCC1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)CS(=O)(=O)C(C)(C)C(=O)N1CCOCC1)[C@@H](N)CC1CC1.
What is the InChIKey of (2S)-N-[(2S)-1-[[(2S,3S,4S)-4-amino-1-cyclohexyl-5-cyclopropyl-3-methylpentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-2-benzyl-3-(2-methyl-1-morpholin-4-yl-1-oxopropan-2-yl)sulfonylpropanamide?
The InChIKey is NDAGRVNTZYWUSP-OYWTUCQVSA-N. The full InChI is InChI=1S/C39H60N6O6S/c1-27(33(40)21-30-14-15-30)34(22-29-12-8-5-9-13-29)43-37(47)35(23-32-24-41-26-42-32)44-36(46)31(20-28-10-6-4-7-11-28)25-52(49,50)39(2,3)38(48)45-16-18-51-19-17-45/h4,6-7,10-11,24,26-27,29-31,33-35H,5,8-9,12-23,25,40H2,1-3H3,(H,41,42)(H,43,47)(H,44,46)/t27-,31+,33-,34-,35-/m0/s1.
What are the key properties of (2S)-N-[(2S)-1-[[(2S,3S,4S)-4-amino-1-cyclohexyl-5-cyclopropyl-3-methylpentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-2-benzyl-3-(2-methyl-1-morpholin-4-yl-1-oxopropan-2-yl)sulfonylpropanamide?
(2S)-N-[(2S)-1-[[(2S,3S,4S)-4-amino-1-cyclohexyl-5-cyclopropyl-3-methylpentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-2-benzyl-3-(2-methyl-1-morpholin-4-yl-1-oxopropan-2-yl)sulfonylpropanamide has a molecular weight of 741.01 g/mol, XLogP of 3.57, 18 rotatable bonds, 4 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-N-[(2S)-1-[[(2S,3S,4S)-4-amino-1-cyclohexyl-5-cyclopropyl-3-methylpentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-2-benzyl-3-(2-methyl-1-morpholin-4-yl-1-oxopropan-2-yl)sulfonylpropanamide is sourced from PubChem (CID 59839033), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).